The RheumNow faculty reporters have been scouring and reporting on the best abstracts from the ACR. Here is a sampling of their choice abstract presentations reported during ACR 2020 Day 3 (#ACRbest).
All News
Article
Richard Conway
Tweet
Our @RheumNow panel discussion of day 1 highlights from #ACR20 with @drdavidliew @jeffsparks @ejdein1 @RHEUMarampa is available now https://t.co/znllruwZlW
sheila
Tweet
Whats your #ACR20 break style?
@RheumNow @rheum_cat @rheumarhyme
sheila
Tweet
#Curcumin for PsA & RA?🤔
Results suggest curcumin's efficacy on pt's perceived symptom alleviation & poss correlation w/ dose and length of tx. @RheumNow #ACR20 abs1230 https://t.co/xUxUEW02ww
sheila
Tweet
Data from Prof. Michelle Petri's study showed double+ or triple+ aPLs were not superior to single LAC+ for risk of thrombosis in #SLE patients. @RheumNow #ACR20 https://t.co/uDHsbd1Y1k
sheila
Tweet
This cohort study presented by @Dr_Alex_Oldroyd shows that early cancer diagnosis after #myositis onset is associated with significantly improved survival.
Cancer screening essential in pts newly diagnosed with IIMs.
@RheumNow #ACR20 abs1057 https://t.co/qVsnTcEnWb
sheila
Tweet
A quote to ignite the senses
@RheumNow #ACR20 https://t.co/174g2oP1gt
#EULAR2020 #op0028 12 wk ph3 RELIEF study: Apremilast effectively relieves OU pain and OU number after 12 wks of 30 mg bid Rx. Great proportion of APR PTs achieved >10 mm &>30 mm improvement in OU pain @RheumNow https://t.co/p71sz9XL0e
Emily Littlejohn
Tweet
Such interesting and important Epi work on the prevalence gradient hypothesis by Gary Gilkeson #ACR20 https://t.co/4LfbpmHjnp
Dr Philip Robinson
Tweet
The @rheum_covid experience with patients with rheumatic disease who are *pregnant* and get COVID-19 is being presented by Bonnie Bermas from UTSouthwestern #ACR20 Sunday 3pm Eastern https://t.co/eeKqMXgpFx
Dr Ai Lyn Tan
Tweet
#Ulcer on lateral portion of mid-#tongue
➡️Giant Cell Arteritis #GCA
➡️#Granulomatosis with polyangiitis #GPA #Wegeners
#Rheumatology pearl by Dr Stone #ACR20
#GiantCellArteritis #vasculitis https://t.co/gTBQVescg9
@CCalabreseDO @MamutMary and I discuss work and work/life balance at #ACR20 https://t.co/mlfDgK4zvz @RheumNow
Meral K. El Ramahi, MD
Tweet
Poll results are in! 75% of those that responded plan to only screen for cardiac manifestations of myositis if a pt develops concerning symptoms. 20% screen for involvement annually w/ a TTE, troponin, BNP, and EKG! @RheumNow #ACR20 https://t.co/crUhFR6Hzf
@RheumNow #ACR20 abs1151 screening for inflammatory hyperferritinemia may be feasible but requires additional info: inflammatory huperferritinemia more likely to correlate with ⬆️IL18, AST&thrombocytosis while high CRP+ferritin more often seen in infectious etiology https://t.co/wiFPXepxpz
sheila
Tweet
Study of Chinese pts on long-term GCs by Dr CC Mok: DEN >> ALN in ⬆spinal BMD & suppressing bone turnover markers after 1yr tx.
No sig. diff in AEs among grps.
Limits: Open-label,small ss,short tx dur'n, not powered for fractures @RheumNow #ACR20 abs1442 https://t.co/m8mT0hMPN8
A Convergence of Ideas: COVID19 and ACR by Dr. Kathryn Dao (@KDAO2011)
#ACR20
https://t.co/0Rxv9GjOkw https://t.co/2uOiOZfSfM
Meral K. El Ramahi, MD
Tweet
Poll results are in! Most would like to wait for a phase III before prescribing MMF with pegloticase in refractory gout. @RheumNow #ACR20 https://t.co/45MpFliDkE


